Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The global clinical trial management market was valued at $570 million in 2016, and is estimated to reach $1,371 million by 2023, registering a CAGR of 13.4% from 2017 to 2023 according to a recently released report.
read more
Wednesday, September 25, 2013
Recipharm Stockholm is pleased to announce that the company was informed on September 20, 2013 by the R&D-based pharmaceutical company, Kyowa Hakko Kirin Co. Ltd. (Tokyo, Japan, President and CEO: Nobuo Hanai, “Kyowa Hakko Kirin”) that Abstral® ...
read more
Thursday, November 05, 2015
Mylan has announced that the U.S. Federal Trade Commission has cleared the company's proposed transaction to acquire Perrigo Company subject to Mylan's divestiture of certain products following the consummation of the offer.
read more
Fette Compacting and CMIC CMO USA have announced a new partnership focused on pharmaceutical manufacturing technology. The collaboration involves integrating Fette Compacting’s FE CPS Continuous Direct Compression system and the FE55 rotary tablet ...
read more
Adherence specialists AARDEX Group are proud to announce its partnership with other industry leaders on DiMe’s new Extending the Verification, Analytical Validation, and Clinical Validation (V3+) Framework project.
read more
Novartis will highlight the strength of its expanded oncology portfolio in 21 medicines and 11 investigational compounds across more than 185 data presentations at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, May 29-June ...
read more
Axplora is strengthening its position in the commercial manufacturing of ADCs with the launch of a cutting-edge payload manufacturing workshop at its Le Mans site (France).
read more
Thursday, August 08, 2013
Sciformix Corporation, a leading Scientific Process Organization (SPO), announces the opening of their new offices located in Manila, the Philippines. The expansion into Manila comes as part of Sciformix‘s continued growth and provides the ...
read more
Thursday, November 19, 2015
Gurnet Point Capital, an investment firm focused on the healthcare and life sciences sectors that was founded by Ernesto Bertarelli and is led by Christopher A. Viehbacher, has announced the creation of Boston Pharmaceuticals.
read more
Wednesday, October 12, 2022
Advarra announced that the Advarra Gene Therapy Ready™ site network has grown to over 1,000 registered research sites. This reinforces Advarra's position as the world's largest administrator of institutional biosafety committees (IBCs) and the most ...
read more
Tuesday, October 14, 2025
Almac Group has unveiled a $48 million investment aimed at advancing eClinical technologies, highlighted by the debut of its new interoperable platform, Almac Trial Coordinator™.
read more
RedHill Biopharma Ltd. has announced the signing of a research collaboration agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), intended to evaluate RedHill’s ...
read more
Wednesday, April 12, 2017
The Lead Discovery Center GmbH (LDC), Max Planck Innovation GmbH (MI) and SOTIO a.s. have signed a collaboration and license agreement providing SOTIO with exclusive rights to an oncology program addressing a novel target in tumor metabolism. It was ...
read more
Sandoz, a Novartis company, has announced the US launch of GlatopaTM, the first generic version of Teva's Copaxone® (glatiramer acetate injection) 20 mg/ml one-time-daily multiple sclerosis therapy.
read more
ICON has acquired a majority shareholding in MeDiNova Research, a site network with research sites in key markets in Europe and Africa.
read more